Buscar
25/06/2024
What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?
Lleó, A, Alcolea, D. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. NEUROLOGY. 2024; 102(12)DOI:10.1212/WNL.0000000000209505. PMID:38830183. IF:8.500(Q1/1D).
13/06/2024
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Navarro-Pérez, MP, González-Quintanilla, V, Muñoz-Vendrell, A, Madrigal, E, Alpuente, A, Latorre, G, Molina, F, Monzón, MJ, Medrano, V, García-Azorín, D, González-Oria, C, Gago-Veiga, A, Velasco, F, Beltrán, I, Morollón, N, Viguera, J, Casas-Limón, J, Rodriguez-Vico, J, Cuadrado, E, Irimia, P, Iglesias, F, Guerrero-Peral, áL, Belvís, R, Pozo-Rosich, P, Pascual, J, Santos-Lasaosa, S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1417831. PMID:38938776. IF:2.800(Q2/5D).
05/06/2024
Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum
Carbayo, A, Borrego-Écija, S, Turon-Sans, J, Cortés-Vicente, E, Molina-Porcel, L, Gascón-Bayarri, J, Rubio, MA, Povedano, M, Gámez, J, Sotoca, J, Juntas-Morales, R, Almendrote, M, Marquié, M, Sánchez-Valle, R, Illán-Gala, I, Dols-Icardo, O, Rubio-Guerra, S, Bernal, S, Caballero-Avila, M, Vesperinas, A, Gelpi, E, Rojas-García, R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7)DOI:10.1093/brain/awae011. PMID:38227807. IF:11.700(Q1/1D).
17/05/2024
The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people
Jacobs, T, Jacobson, SR, Fortea, J, Berger, JS, Vedvyas, A, Marsh, K, He, TS, Gutierrez-Jimenez, E, Fillmore, NR, Gonzalez, M, Figueredo, L, Gaggi, NL, Plaska, CR, Pomara, N, Blessing, E, Betensky, R, Rusinek, H, Zetterberg, H, Blennow, K, Glodzik, L, Wisniweski, TM, de Leon, MJ, Osorio, RS, Ramos-Cejudo, J. The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people. Immunity & Ageing. 2024; 21(1)DOI:10.1186/s12979-024-00435-2. PMID:38760856. IF:5.600(Q1/1D).
11/05/2024
Addressing challenges in health care and research for people with Down syndrome
Fortea, J, McGlinchey, E, Espinosa, JM, Rafii, MS. Addressing challenges in health care and research for people with Down syndrome. LANCET. 2024; 403(10439)DOI:10.1016/S0140-6736(24)00478-1. PMID:38521088. IF:88.500(Q1/1D).
23/04/2024
On the road to biological blood diagnosis of Alzheimer's disease?
Delaby, C, Lehmann, S. On the road to biological blood diagnosis of Alzheimer's disease?. M S-MEDECINE SCIENCES. 2024; 40(4)DOI:10.1051/medsci/2024037. PMID:38651960. IF:0.400(Q4/10D).
01/04/2024
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
García-Azorín, D, Martínez-Badillo, C, Muñiz, JC, Gago-Veiga, AB, Sánchez, NM, González-Quintanilla, V, Porta-Etessam, J, Sierra-Mencia, A, Gonzalez-Garcia, N, González-Osorio, Y, Polanco-Fernandez, M, Recio-García, A, Nieto, RB, Guerrero-Peral, AL. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. CEPHALALGIA. 2024; 44(4)DOI:10.1177/03331024241248833. PMID:38663908. IF:4.600(Q1/2D).
28/03/2024
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors
Swift, IJ, Rademakers, R, Finch, N, Baker, M, Ghidoni, R, Benussi, L, Binetti, G, Rossi, G, Synofzik, M, Wilke, C, Mengel, D, Graff, C, Takada, LT, Sanchez-Valle, R, Antonell, A, Galimberti, D, Fenoglio, C, Serpente, M, Arcaro, M, Schreiber, S, Vielhaber, S, Arndt, P, Santana, I, Almeida, MR, Moreno, F, Barandiaran, M, Gabilondo, A, Stubert, J, Gomez-Tortosa, E, Agueero, P, Sainz, MJ, Gohda, T, Murakoshi, M, Kamei, N, Kittel-Schneider, S, Reif, A, Weigl, J, Jian, JL, Liu, CJ, Serrero, G, Greither, T, Theil, G, Lohmann, E, Gazzina, S, Bagnoli, S, Coppola, G, Bruni, A, Quante, M, Kiess, W, Hiemisch, A, Jurkutat, A, Block, MS, Carlson, AM, Bråthen, G, Sando, SB, Grontvedt, GR, Lauridsen, C, Heslegrave, A, Heller, C, Abel, E, Gómez-Núñez, A, Puey, R, Arighi, A, Rotondo, E, Jiskoot, LC, Meeter, LHH, Duraes, J, Lima, M, Tábuas-Pereira, M, Lemos, J, Boeve, B, Petersen, RC, Dickson, DW, Graff-Radford, NR, Leber, I, Sellami, L, Lamari, F, Clot, F, Borroni, B, Cantoni, V, Rivolta, J, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I, Andres-Cerezo, L, Van Damme, P, Clarimon, J, Steinacker, P, Feneberg, E, Otto, M, van der Ende, EL, van Swieten, JC, Seelaar, H, Zetterberg, H, Sogorb-Esteve, A, Rohrer, JD. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Research & Therapy. 2024; 16(1)DOI:10.1186/s13195-024-01420-z. PMID:38539243. IF:7.600(Q1/1D).